VYGR – voyager therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Voyager Therapeutics Announces First Participants Dosed in Single Ascending Dose Trial of VY-TAU01 for the Treatment of Alzheimer's Disease [Yahoo! Finance]
Voyager Therapeutics Announces First Participants Dosed in Single Ascending Dose Trial of VY-TAU01 for the Treatment of Alzheimer’s Disease
Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $18.00 price target on the stock.
Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its price target lowered by analysts at Wedbush from $10.00 to $8.00. They now have a "neutral" rating on the stock.
Form 8-K Voyager Therapeutics, For: May 16
Form 10-Q Voyager Therapeutics, For: Mar 31
Form 8-K Voyager Therapeutics, For: May 13
Form ARS Voyager Therapeutics, For: Dec 31
Form DEFA14A Voyager Therapeutics,
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.